Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Intel stunned investors in 2026 with a 225% surge. This guide explores the factors behind that rally and what it coul...
OpenAI just signaled might delay its IPO, sending ripples through AI investors and chipmakers. This guide breaks down...
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
One large investor dumped 783,379 Truth Social shares, triggering a sharp move in the stock. This article explains wh...
Big tech pullbacks can create compelling opportunities. This guide examines whether amazon alphabet among best stocks...
Archer Aviation is venturing into urban air mobility with electric VTOL aircraft. This piece analyzes the case for bu...
When markets hit new highs, Berkshire Hathaway's leaders offer a different playbook. Learn how Warren Buffett's Greg ...
A big order from China could reshape Boeing's outlook and affect your investments. This guide breaks down the implica...
JPMorgan argues the macro bet that fueled Bitcoin gains is cooling, with BTC near $63,000 as markets digest easing te...
XRP is under renewed pressure after a harsh stretch of declines, with traders weighing the risk of deeper losses agai...
When an energy storage company reports stronger results, the market often reacts with a sharp stock move. This guide ...